These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 20452419)
21. Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseases. Markart P; Luboeinski T; Korfei M; Schmidt R; Wygrecka M; Mahavadi P; Mayer K; Wilhelm J; Seeger W; Guenther A; Ruppert C Antioxid Redox Signal; 2009 Feb; 11(2):227-40. PubMed ID: 18783310 [TBL] [Abstract][Full Text] [Related]
22. Anti-fibrotic strategies and pulmonary fibrosis. Gunatilaka A; Zhang S; Tan WSD; G Stewart A Adv Pharmacol; 2023; 98():179-224. PubMed ID: 37524487 [TBL] [Abstract][Full Text] [Related]
23. Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis. Boesch M; Baty F; Brutsche MH; Tamm M; Roux J; Knudsen L; Gazdhar A; Geiser T; Khan P; Hostettler KE Respir Res; 2020 Jun; 21(1):165. PubMed ID: 32605572 [TBL] [Abstract][Full Text] [Related]
24. Comparative proteomic analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and lung transplant donor lungs. Korfei M; Schmitt S; Ruppert C; Henneke I; Markart P; Loeh B; Mahavadi P; Wygrecka M; Klepetko W; Fink L; Bonniaud P; Preissner KT; Lochnit G; Schaefer L; Seeger W; Guenther A J Proteome Res; 2011 May; 10(5):2185-205. PubMed ID: 21319792 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of Proteasome Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis. Chen IC; Liu YC; Wu YH; Lo SH; Dai ZK; Hsu JH; Tseng YH Cells; 2022 May; 11(9):. PubMed ID: 35563849 [TBL] [Abstract][Full Text] [Related]
26. Role of antioxidants in the treatment of gastroesophageal reflux disease-associated idiopathic pulmonary fibrosis. Nelkine L; Vrolijk MF; Drent M; Bast A Curr Opin Pulm Med; 2020 Jul; 26(4):363-371. PubMed ID: 32452901 [TBL] [Abstract][Full Text] [Related]
27. Exploitation of Novel Molecular Targets to Treat Idiopathic Pulmonary Fibrosis: A Drug Discovery Perspective. Vaidya B; Patel R; Muth A; Gupta V Curr Med Chem; 2017; 24(22):2439-2458. PubMed ID: 28552057 [TBL] [Abstract][Full Text] [Related]
28. Curcumin induced oxidative stress attenuation by N-acetylcysteine co-treatment: a fibroblast and epithelial cell in-vitro study in idiopathic pulmonary fibrosis. Rodriguez LR; Bui SN; Beuschel RT; Ellis E; Liberti EM; Chhina MK; Cannon B; Lemma M; Nathan SD; Grant GM Mol Med; 2019 Jun; 25(1):27. PubMed ID: 31195971 [TBL] [Abstract][Full Text] [Related]
32. Homeostatic chemokines as putative therapeutic targets in idiopathic pulmonary fibrosis. Russo RC; Quesniaux VFJ; Ryffel B Trends Immunol; 2023 Dec; 44(12):1014-1030. PubMed ID: 37951789 [TBL] [Abstract][Full Text] [Related]
33. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model. Selman M; Pardo A Am J Respir Crit Care Med; 2014 May; 189(10):1161-72. PubMed ID: 24641682 [TBL] [Abstract][Full Text] [Related]
37. Unraveling the interplay between vital organelle stress and oxidative stress in idiopathic pulmonary fibrosis. Mohanan A; Washimkar KR; Mugale MN Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119676. PubMed ID: 38242330 [TBL] [Abstract][Full Text] [Related]
38. Cellular senescence and autophagy in the pathogenesis of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). Kuwano K; Araya J; Hara H; Minagawa S; Takasaka N; Ito S; Kobayashi K; Nakayama K Respir Investig; 2016 Nov; 54(6):397-406. PubMed ID: 27886850 [TBL] [Abstract][Full Text] [Related]
39. Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis. Kou L; Kou P; Luo G; Wei S Oxid Med Cell Longev; 2022; 2022():6197219. PubMed ID: 35345828 [TBL] [Abstract][Full Text] [Related]